Calls of the day: Nvidia, Bed, Bath, & Beyond & more

Here are the biggest calls on Wall Street on Tuesday.

PiperJaffray initiated Nvidia as 'overweight'

PiperJaffray initiated coverage on Nvidia saying they expect the gaming industry to continue to grow.

"We are initiating NVIDIA with an Overweight rating as we believe it is trading at attractive levels given its exposure and market positioning in several secular trends... In our opinion, despite recent headwinds, gaming is primed for growth in the second half of the year, as we see gaming growing year-over-year from its $1.4 billion run-rate... We also see the data center and automotive markets as two long-term secular growth markets, especially given NVIDIA's product positioning and recently announced Mellanox acquisition... Additionally, we believe NVIDIA has the opportunity for significant margin expansion from levels in the most recent quarter... As the company executes, we expect NVIDIA's earnings to grow rapidly... At a price of $173.78, NVIDIA trades at 33.3x our fiscal 2020E non-GAAP EPS of $5.22. Our 12-month PT of $200 is based on a P/E multiple of ~38x our fiscal 2020 EPS estimate..."

Raymond James upgraded Bed, Bath, & Beyond to 'strong buy' from 'market perform'

Raymond James upgraded the stock after a Wall Street Journal report said that some shareholders are looking to replace the board of the company.

"This upgrade comes directly on the heels of the late Monday evening WSJ article highlighting that a select group of shareholders plan to wage a campaign to replace the entire 12- member board of Bed Bath & Beyond and shortly before the company's F4Q18 report... The activists emergence coincides with this note, which we have been preparing for weeks to highlight that within the foreseeable future, Bed Bath & Beyond may either no longer be a public company or on a journey to go private... If that happens, clients that have shorted the shares (33% of float) would be damaged... While the analysis in this note is centered on a potential take-out case, many of the same merits that make Bed Bath & Beyond attractive for a takeout also hold true from an activist standpoint... The most difficult issue facing all investors is the same: management's irritating lack of transparency...."

Deutsche Bank upgraded BB&T to 'buy' from 'hold'

Deutsche Bank is positive on the merger between BB&T and SunTrust.

"We remain positive on the merger of BBT/STI and the combined stock... As a result, we are upgrading BBT to Buy to be consistent with our Buy rating on STI... Note that since the day after the BBT/STI deal was announced on Feb 7, BBT shares are down 11% (STI is -12%) vs. -6% for the BKX Index and +4% for the S&P 500... This follows a 4% rise in BBT and 10% increase in STI the day the deal was announced (vs. peers up less than 1%)..."

Bernstein initiated Dow Inc. as 'overweight'

Bernstein expects investors to react positively to the new Dow which is a a chemical company that will be spun off from DowDupont on April 1st.

"We initiate coverage of Dow with an Outperform rating and a target price of $74/share, driven by our belief that tightening ethylene markets will yield an upcycle in 2020... Tactically, we see a compelling entry point in mid- to late-April, as we expect the stock to sell off immediately after the spin before it moves up to our target price over the next year.... Dow will be spun out of DowDuPont as a distribution to DWDP shareholders on April 1st... We expect Dow shares to trade down immediately following the spin based on conversations with investors, and the precedent of other spinouts... We expect that Dow shares will recover over the next 12 months as resilient fundamentals segue into an outright ethylene upcycle in 2020 that will drive US integrated ethane margins to ~$1200/tonne. This will drive Dow EBITDA from $9.1bln in 2018 to $14.5bln in 2020. Though the ethylene upcycle will likely only last for 1-2 years, we expect Dow shares to follow margins..."

RH (RH) Q4 2018 Earnings Conference Call Transcript

Image source: The Motley Fool.

RH (NYSE:RH) Q4 2018 Earnings Conference CallMarch 28, 2019 5:00 p.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Good afternoon. My name is Erica and I will be your conference operator today. [Operator instructions] RH fourth quarter and fiscal 2018 earnings Q&A conference call. [Operator instructions] After the speaker's remarks, there will be a question-and-answer session. [Operator instructions] Thank you. Miss Cammeron McLaughlin, RH investor relations, you may begin your conference.

Cammeron McLaughlin -- Investor Relations

Thank you. Good afternoon, everyone. Thank you for joining us for RH's fourth quarter and fiscal 2018 Q&A conference call. Joining me today are Gary Friedman, chairman and chief executive officer; Ryno Blignaut, president, chief financial, and administrative officer; and Jack Preston, our incoming chief financial officer.

Before we start, I would like to remind you of our legal disclaimer that we will make certain statements today that are forward-looking within the meaning of the federal securities laws, including statements about the outlook for our business and other matters referenced in our press release issued today. These forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially. Please refer to our SEC filings as well as our press release issued today for a more detailed description of the risk factors that may affect our results. Please also note that these forward-looking statements reflect our opinions only as of the date of this call, and we undertake no obligation to revise or publicly release the results of [Audio gap] statements in light of new information or future events.

Also during our call today, we may discuss non-GAAP financial measures, which adjust our GAAP results to eliminate the impact of certain items. You will find additional information regarding these non-GAAP financial measures and a reconciliation of these non-GAAP to GAAP measures in today's financial results press release. A live broadcast of this call is also available on the Investor Relations section of our website at ir.rh.com. With that, I'll turn the call over to Gary for some brief opening remarks and then we'll begin our Q&A session.

Gary Friedman -- Chairman and Chief Executive Officer

Right. Thank you, Cammeron. Thank you for joining us today. Before we start, I'd like to congratulate Jack for his appointment to CFO and welcome him to his first earnings call. Based on how the stock's trading in after hours, Jack it's a little baptism by fire but he's up for the task. As you know, Jack has been in senior positions with RH for six years most recently as our senior vice president of finance and our chief strategy officer. In reality, Jack and I have been working together for almost nine years now.

Jack Preston -- Incoming Chief Financial Officer

That's right.

Gary Friedman -- Chairman and Chief Executive Officer

As he was a key advisor to the company for, I think, three years prior in preparation for our IPO. So it seems like it's almost 10 years. But in the six years that Jack has been with RH, he's had a seat at the table, participating that the most senior levels of the entire time including many of our board meetings. And I believe I speak for the entire team that, Jack, we're so proud of you and so excited to have you in this position. You have earned it. So welcome.

Jack Preston -- Incoming Chief Financial Officer

Thank you.

Gary Friedman -- Chairman and Chief Executive Officer

I'd also like to thank Ryno for the past eight months and especially for the past several weeks as he's worked to ensure a seamless transition with Jack. Ryno and I were dating for a long, long time and probably longer -- longer than we get to work together and so -- well, I feel it's unfortunate. I know it's really best for Reno and his family and I want to thank Reno and wish you and your family nothing but the best from all of us on our team RH.

Ryno Blignaut -- President, Chief Financial, and Administrative Officer

Great. Well, thank you. Gary. Thank you for the opportunity you gave me. Clearly this was a very hard and unfortunate decision. But as you just said, it is the right one for me and for RH. You and the team deserve somebody who can give 150%. Unfortunately, I can't do that at the moment but we're very fortunate to have somebody as experienced as Jack, who can do that, and be able to step in for a smooth, smooth transition. So with that, I think we'll hand it over to the operator for questions. 

Questions and Answers:

Operator

[Operator instructions] And our first question comes from Steve Forbes with Guggenheim Securities.

Steve Forbes -- Guggenheim Securities -- Analyst

Good afternoon. So I mean maybe, Gary, I wanted to start with the change in the revenue growth outlook for '19. Obviously, a lot has transpired over the past three months but it is a short three months. So maybe just help us understand your confidence in the renewed outlook. What could go wrong from here as you kind of think about end demand for your consumer and sort of like how have you got everything now, right, because it appears to me that the implied comp would be very modest if you think about everything that's sort building from the real estate transformation effort and potentially some outlook growth.

Gary Friedman -- Chairman and Chief Executive Officer

Yeah, well, one where we're as confident that we can -- as confident as we can be with our outlook, look, we gave our last outlook on December 3rd and after market closed and on December 4th, as many of you know, we launched a convert. And our stock was, I think, trading after hours in the $1.60s and closed that day at $1-40-something. We started a conference call with the convertible debt. I think we had 40 people on the call.

I gave a 20-minute presentation and asked for questions and it was crickets and the bankers asked for questions and it was crickets. And we found out in the 20 minutes we were talking, the market dropped 400 points on its way to down 800 points and on its way to down 4,000 points in the month of December. And, look, our business is tied to the high-end consumer. It's really the top -- if we've got some echo in the background.

Cammeron McLaughlin -- Investor Relations

I mean, it's on Steve's maybe?

Gary Friedman -- Chairman and Chief Executive Officer

Yeah. [Inaudible] But we deal with the high-end consumer. They're tied to the stock market. It shouldn't be any new news to anybody that like severe volatility in the stock market is going to sway a business like ours, especially a high ticket business like ours that can be pretty discretionary.

So for what we can control, we're super confident. Look we -- I mean, yes, let's step back for a minute and start with the fact that we we guided 2018 for 9% to 10% operating margins and many people thought we couldn't make it and thought we're too aggressive guiding 9% to 10%. We raised guidance four times during the year from an earnings point of view and we beat guidance all four times after -- including the fourth quarter. And we told everybody we're in to manage the business with a bias for four earnings versus revenue growth as we try to optimize this model and build the most differentiated and profitable business in our space.

And so, look, if we were playing the old game, in the fourth quarter, ifour business would've dropped 10 points, we would have pulled a bunch of promotional levers and we would've done a lot of things like everybody else does and you would've seen a zillion emails that are at the end of the day downward spiral and it's detrimental to a brand and to your long-term positioning. And we're just not playing that game anymore. So we took the hit on the top line. We think that the business remain tough all the way through January and into February, and we've seen our business now picking up.

We feel confident about the outlook but I can't control -- and none of us can. Yeah, I mean, anybody on this call, did they forecast what was going to happen in December? I mean, I sure couldn't on December 3rd. So look, we just have the best year in the company's history. We had -- $2.5 billion company making 12.1 % operating margins. Name another home furnishings company that's expanding operating margins like we are, that's building a model like we are. We feel great about where we are. I mean, it's -- the stock goes down, we'll buy more stock. I'll buy more stock.

It's that's OK. We'll take advantage of this on both sides. So it is a great day for Team Resto. We're indifferent that the stock's bouncing around. I don't know. What is it down? 20 points? We're the best earnings in our sector by far. And so that's what we feel proud about. Do I feel bad that we took earnings guidance up on Dece

Sorrento Therapeutics News: Why SRNE Stock Is On The Move

Recent Sorrento Therapeutics news has SRNE stock on a roller coaster ride today.

Source: Shutterstock

Sorrento Therapeutics (NASDAQ:SRNE) announced today that its majority owned subsidiary Scilex Pharmaceuticals is merging with Semnur Pharmaceuticals. This merger has the two companies coming together in an effort to create a leader in the non-opioid pain medicine market. The new company’s name is Scilex Holding Company

The Sorrento Therapeutics news means that the company’s stake in Scilex Pharmaceuticals is being converted into a new stake at the combined company. This has its 77% stake in Scilex Pharmaceuticals becoming a 58% stake in Scilex Holding Company.

“This transaction is highly synergistic,” Dr. Henry Ji, Chairman and CEO of Sorrento Therapeutics, said in a statement. “Scilex has built up a commercial organization with over 100 highly experienced sales representatives, fully staffed marketing, market access, and medical liaison teams while Semnur has a very exciting Phase 3 compound in non-opioid pain management.”

Scilex Pharmaceuticals’ ZTlido is already performing well in the early months of its commercial release. Semnur also has a compound that is in a Phase 3 trial and could also be a strong win for the newly-merged company.

The Sorrento Therapeutics news today has SRNE stock on a wild ride. It started off up up 8% on Friday morning and reached a peak increase of 24% during morning trading. However, the stock is now down 9% as of Friday afternoon.

As of this writing, William White did not hold a position in any of the aforementioned securities.

Compare Brokers

Ichor (ICHR) Shares Up 6.5%

Ichor Holdings Ltd (NASDAQ:ICHR) was up 6.5% during trading on Friday . The company traded as high as $22.25 and last traded at $21.89. Approximately 761,517 shares changed hands during mid-day trading, an increase of 87% from the average daily volume of 406,724 shares. The stock had previously closed at $20.56.

A number of equities research analysts have recently commented on ICHR shares. Needham & Company LLC lifted their price objective on Ichor to $27.00 and gave the company a “buy” rating in a research report on Thursday, February 7th. Zacks Investment Research downgraded Ichor from a “hold” rating to a “strong sell” rating in a research report on Thursday, January 31st. BidaskClub raised Ichor from a “hold” rating to a “buy” rating in a research report on Saturday, February 2nd. ValuEngine downgraded Ichor from a “hold” rating to a “sell” rating in a research report on Thursday, March 7th. Finally, DA Davidson started coverage on Ichor in a research report on Thursday, March 7th. They issued a “buy” rating and a $30.00 price objective for the company. Two analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company’s stock. Ichor currently has an average rating of “Hold” and an average price target of $28.17.

Get Ichor alerts:

The firm has a market cap of $459.91 million, a price-to-earnings ratio of 7.85 and a beta of 2.85. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.41 and a quick ratio of 1.03.

Ichor (NASDAQ:ICHR) last issued its earnings results on Wednesday, February 6th. The technology company reported $0.27 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.31 by ($0.04). Ichor had a net margin of 7.03% and a return on equity of 30.78%. The firm had revenue of $141.40 million during the quarter, compared to analyst estimates of $144.20 million. During the same quarter in the previous year, the business posted $0.70 EPS. Ichor’s revenue was down 22.7% compared to the same quarter last year. As a group, research analysts expect that Ichor Holdings Ltd will post 1.56 earnings per share for the current fiscal year.

In other Ichor news, CTO Philip Ryan Sr. Barros sold 28,457 shares of the business’s stock in a transaction dated Wednesday, February 13th. The stock was sold at an average price of $21.57, for a total transaction of $613,817.49. Following the transaction, the chief technology officer now owns 33,062 shares in the company, valued at $713,147.34. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Kevin M. Canty sold 1,750 shares of the business’s stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $21.89, for a total value of $38,307.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the business. Sapphire Star Partners LP lifted its stake in shares of Ichor by 2.8% during the fourth quarter. Sapphire Star Partners LP now owns 25,916 shares of the technology company’s stock worth $422,000 after purchasing an additional 718 shares in the last quarter. Whittier Trust Co. lifted its stake in shares of Ichor by 7.7% during the fourth quarter. Whittier Trust Co. now owns 28,460 shares of the technology company’s stock worth $464,000 after purchasing an additional 2,023 shares in the last quarter. Financial Architects Inc acquired a new position in shares of Ichor during the fourth quarter worth about $41,000. SevenBridge Financial Group LLC lifted its stake in shares of Ichor by 212.5% during the fourth quarter. SevenBridge Financial Group LLC now owns 3,750 shares of the technology company’s stock worth $61,000 after purchasing an additional 2,550 shares in the last quarter. Finally, Quantamental Technologies LLC acquired a new position in shares of Ichor during the fourth quarter worth about $47,000. Institutional investors own 97.66% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/4224645/ichor-ichr-shares-up-6-5.html.

About Ichor (NASDAQ:ICHR)

Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment in the United States, the United Kingdom, Singapore, Malaysia, and South Korea. It primarily offers gas and chemical delivery subsystems that are used in the manufacturing of semiconductor devices.

Featured Article: Closed-End Mutual Funds (CEFs)

Top 10 Growth Stocks For 2019

tags:ISRG,TBI,JWN,BWLD,MED,

Brokerages predict that Talend SA (NASDAQ:TLND) will announce $51.87 million in sales for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Talend’s earnings. The highest sales estimate is $52.00 million and the lowest is $51.60 million. Talend reported sales of $38.40 million during the same quarter last year, which indicates a positive year-over-year growth rate of 35.1%. The firm is scheduled to report its next earnings report on Thursday, November 8th.

On average, analysts expect that Talend will report full year sales of $204.92 million for the current fiscal year, with estimates ranging from $204.71 million to $205.30 million. For the next year, analysts anticipate that the business will post sales of $260.91 million per share, with estimates ranging from $255.50 million to $268.24 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Talend.

Top 10 Growth Stocks For 2019: Intuitive Surgical Inc.(ISRG)

Advisors' Opinion:

• [By Jason Hall, Sean Williams, and Jordan Wathen]

  We asked three investors who regularly contribute to The Motley Fool to help us identify some of the "wonderful" companies, and they made strong cases for Mastercard Inc. (NYSE:MA), Intuitive Surgical, Inc. (NASDAQ:ISRG), and Pattern Energy Group Inc. (NASDAQ:PEGI). These are three very different companies, but they share some important traits that make them worth your consideration as "ultra-long-term" investments: Big long-term trends driving their business prospects for many years of growth, and excellent management with strong track records of success.

• [By ]

  As of the time of this article, home cleaning robot maker iRobot's (IRBT) shares are down over 6% on the news. And though it makes surgical robots rather than anything meant for homes, Intuitive Surgical  (ISRG) is down close to 2%. As usual, Wall Street immediately trembles on any sign that Amazon plans to further expand its reach.

• [By Keith Speights]

  Intuitive Surgical (NASDAQ:ISRG) is best known for its da Vinci robotic surgical system. Johnson & Johnson (NYSE:JNJ) might be most famous for its consumer healthcare products. But there's a lot more to picking between these two stocks than just comparing robots and Band-Aids.

• [By Garrett Baldwin]

  Earnings season is now in full swing, with today's key reports from International Business Machines Corp. (NYSE: IBM), Johnson & Johnson (NYSE: JNJ), and Intuitive Surgical Inc. (Nasdaq: ISRG). Thanks to tax cuts, expectations are high. Analysts expect profit growth to top 18%, which would be the biggest jump in seven years. But there are a few bearish trends that are still lurking in the market. And if you're serious about making money, you need to know how to harness them and target individual stocks for life-changing gains. Money Morning Quantitative Specialist Chris Johnson explains.

Top 10 Growth Stocks For 2019: TrueBlue Inc.(TBI)

Advisors' Opinion:

• [By Joseph Griffin]

  Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Trueblue (TBI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

Top 10 Growth Stocks For 2019: Nordstrom Inc.(JWN)

Advisors' Opinion:

• [By ]

  Cramer and the AAP team are sharing a positive research note on Norstrom (JWN) , and their analysis. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS. 

• [By Motley Fool Staff]

  In this clip, host Chris Hill and Motley Fool contributor Ron Gross go through the most important numbers and trends from Nordstrom (NYSE:JWN), Macy's (NYSE:M), and JC Penney (NYSE:JCP), explain why the stocks went in the directions they did after reports came out, and take a peek at the long-term health of each mall-based retailer.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Nordstrom (JWN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Jeremy Bowman]

  Still, plenty of investors are likely wondering if Stitch Fix (NASDAQ:SFIX) is a good buy before its fourth-quarter earnings report, due out on Oct. 1 after market close. The company is unique on the stock market as an online personalized styling service: It ships clothes to customers based on fit and style preferences rather than allowing customers to choose the items directly. Though it has competitors in that sector, including Nordstrom's (NYSE:JWN) Trunk Club, Stitch Fix is far and away the leader in the segment; sales are projected to be $1.23 billion this fiscal year.

Top 10 Growth Stocks For 2019: Buffalo Wild Wings Inc.(BWLD)

Advisors' Opinion:

• [By Steve Symington]

  That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

• [By Peter Graham]

  A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:

Top 10 Growth Stocks For 2019: MEDIFAST INC(MED)

Advisors' Opinion:

• [By Lisa Levin]

  Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

• [By Joseph Griffin]

  MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.

• [By Ethan Ryder]

  MediBloc (CURRENCY:MED) traded 3.9% lower against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on June 13th. One MediBloc token can now be purchased for $0.0083 or 0.00000131 BTC on major cryptocurrency exchanges including Coinrail, Gate.io and Bibox. During the last seven days, MediBloc has traded 36.5% lower against the U.S. dollar. MediBloc has a total market cap of $24.58 million and $216,935.00 worth of MediBloc was traded on exchanges in the last day.

• [By Ethan Ryder]

  MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

• [By Logan Wallace]

  State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.

Top 5 Medical Stocks To Invest In Right Now

tags:BLDP,QBAK,CRS,MMS,MDCA,

It’s been a banner year for the pot industry.

New public sentiment on pot, medical breakthroughs, legalization, and huge fortunes…

The list could goes on and on with ways pot has stolen the headlines.

The future of pot in the U.S. and abroad, as a commoditized and regulated industry, is looking very bright.

And very lucrative.

It’s almost easy to forget that not long ago cannabis was a vilified substance.

But, in an incredibly short amount of time marijuana has rebranded itself completely.

Instead of stoney hippies, when you think of the pot industry today, the images of high quality laboratories, politicians, and venture capitalists come to mind.

It's one of the most successful rebrandings of a product ever seen.

Now that marijuana has completely revamped its image the big bucks are flowing.

Today we look at some of the most recent marijuana news set to move the needle in 2018.

Huge Loophole Opportunity in California

A recently discovered loophole in California's marijuana laws means non-residents could open and conduct business in the state.

Top 5 Medical Stocks To Invest In Right Now: Ballard Power Systems, Inc.(BLDP)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Ballard Power Systems (BLDP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By John Bromels]

  Once upon a time -- like, 10 years ago -- hydrogen fuel cells were seen as a leading contender for mass-producing green energy vehicles. Companies like Plug Power and Ballard Power Systems (NASDAQ:BLDP) have turned that potential into reality -- kind of. 

• [By Motley Fool Transcription]

  Ballard Power Systems Inc.  (NASDAQ:BLDP) Q4 and Full Year 2018 Earnings Conference Call March. 07, 2019, 8:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Travis Hoium]

  Shares of Ballard Power Systems Inc (NASDAQ:BLDP) jumped as much as 11.9% in trading Tuesday after the company announced the sale of some noncore assets. At 12:40 p.m. EDT, shares were still up 9.1% on the day.

Top 5 Medical Stocks To Invest In Right Now: Qualstar Corporation(QBAK)

Advisors' Opinion:

• [By Max Byerly]

  Qualstar (NASDAQ:QBAK) issued its quarterly earnings data on Wednesday. The electronics maker reported $0.23 earnings per share for the quarter, Bloomberg Earnings reports. Qualstar had a net margin of 10.52% and a return on equity of 20.76%. The business had revenue of $3.23 million during the quarter.

• [By Ethan Ryder]

  Media headlines about Qualstar (NASDAQ:QBAK) have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Qualstar earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned news headlines about the electronics maker an impact score of 45.8526636437463 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Top 5 Medical Stocks To Invest In Right Now: Carpenter Technology Corporation(CRS)

Advisors' Opinion:

• [By Max Byerly]

  Crystal Amber Fund Limited (LON:CRS) announced a dividend on Friday, July 6th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, July 19th will be given a dividend of GBX 2.50 ($0.03) per share on Friday, August 17th. This represents a yield of 1.12%. The ex-dividend date is Thursday, July 19th. The official announcement can be viewed at this link.

• [By Ethan Ryder]

  Titan International (NYSE: TWI) and Carpenter Technology (NYSE:CRS) are both industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

• [By Logan Wallace]

  Carpenter Technology Co. (NYSE:CRS) VP Timothy Lain sold 1,007 shares of the firm’s stock in a transaction that occurred on Friday, May 4th. The stock was sold at an average price of $55.00, for a total transaction of $55,385.00. Following the completion of the transaction, the vice president now directly owns 11,288 shares of the company’s stock, valued at $620,840. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Carpenter Technology (CRS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Invest In Right Now: Maximus, Inc.(MMS)

Advisors' Opinion:

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Maximus (MMS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  Violich Capital Management Inc. purchased a new stake in MAXIMUS, Inc. (NYSE:MMS) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,280 shares of the health services provider’s stock, valued at approximately $204,000.

• [By Stephan Byrd]

  Shares of MAXIMUS, Inc. (NYSE:MMS) have received an average recommendation of “Hold” from the six ratings firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $71.33.

Top 5 Medical Stocks To Invest In Right Now: MDC Partners Inc.(MDCA)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss. Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings. Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance. Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results. Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday. BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years. Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint. Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results. Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates. Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings. Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share. Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m
• [By Ethan Ryder]

  Here are some of the news stories that may have effected Accern’s analysis:

  Get MDC Partners alerts: $0.09 Earnings Per Share Expected for MDC Partners Inc (MDCA) This Quarter (americanbankingnews.com) Head-To-Head Review: MDC Partners (MDCA) vs. HAVAS (HAVSF) (americanbankingnews.com) Telaria (TLRA) & MDC Partners (MDCA) Head to Head Survey (americanbankingnews.com) Comparing WPP (WPP) & MDC Partners (MDCA) (americanbankingnews.com)

  Shares of MDC Partners traded up $0.15, reaching $4.80, during midday trading on Monday, according to Marketbeat.com. 391,100 shares of the company were exchanged, compared to its average volume of 478,690. The stock has a market cap of $278.13 million, a PE ratio of 7.87, a P/E/G ratio of 1.99 and a beta of 1.13. MDC Partners has a 1-year low of $3.80 and a 1-year high of $12.26. The company has a debt-to-equity ratio of -3.37, a current ratio of 0.74 and a quick ratio of 0.74.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on MDC Partners (MDCA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Evan Niu, CFA]

  Shares of MDC Partners (NASDAQ:MDCA) have gotten crushed today, down by a whopping 36% as of 11:45 a.m. EDT, after the company reported first-quarter earnings results and lowered its outlook for organic revenue growth this year.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on MDC Partners (MDCA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By ]

  In particular, Birchenough notes that he has increased confidence in the results due for Aeglea's lead product candidate pegzilarginase- an enzyme replacement therapy for the treatment of Arginase deficiency and solid tumors.

  MDC Partners (MDCA) Current share price: $7.55

  Keep a close eye on MDC Partners- a fast-growing marketing and communications network. Most interestingly, MDC has just been upgraded by five-star Wells Fargo analyst Peter Stabler. His shift in sentiment comes with a bullish $11 price target (46% upside potential).

Top 10 Performing Stocks To Watch Right Now

tags:DOV,COLM,CDTX,VNET,BCPC,PME,MNR,MTDR,HBHC,CSTM,

Verizon Communications Inc. (NYSE: VZ) replaces Exxon Mobil this week as the worst-performing stock on the Dow Jones Industrial Average (DJIA) index, a position it last held in February. The stock has lost 8.84% for the year to date.

The shares dropped by just 9 cents last week (less than 0.2%), but that was enough to drop the stock to the bottom of the Dow 30.

Investors remain concerned about the hit to revenues that may follow the adoption of the company’s unlimited data plan. With all four major U.S. wireless carriers now offering unlimited data plans, has the industry embarked on a race to the bottom?

Analysts at Jefferies warned:

While the industry remains bullish on growth in data usage, and metered plans allow for some continued enthusiasm, the move by every carrier to unlimited plans will cause carriers to hope for less and less data usage. Almost every pricing action over the last couple of years has continued to take the roof down on ARPU growth opportunities as more and more data was offered for the same, or lower price point. Now with the advent of unlimited plans, the upside from additional usage is gone for those choosing aggressively priced unlimited plans.

Top 10 Performing Stocks To Watch Right Now: Dover Corporation(DOV)

Advisors' Opinion:

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Dover Corp. (NYSE: DOV) which traded down about 18% at $76.68. The stock's 52-week range is $75.88 to $109.06. Volume was 3.7 million compared to the daily average volume of 1.6 million.

• [By ]

  Dover Corp. (NYSE: DOV) is a diversified global manufacturer of equipment, components, systems and solutions in four segments: engineered systems, fluids, refrigeration and food equipment, and energy. The 2017 hike marked the 62nd consecutive year of hikes. Looking ahead, the company's CEO expects more acquisitions that would contribute to higher margins and completion of the current share buy back program. The 2018 hike marked the 63rd consecutive year of hikes.

• [By ]

  Dover Corp. (NYSE: DOV) spans multiple industries for equipment and components, pumps, conveyors and other items used by manufacturers and goods-producing companies. Its dividend hike in August 2018 marked the 63rd consecutive year of dividend hikes since its founding in 1947.

Top 10 Performing Stocks To Watch Right Now: Columbia Sportswear Company(COLM)

Advisors' Opinion:

• [By Shane Hupp]

  Columbia Sportswear (NASDAQ:COLM) hit a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $88.86 and last traded at $88.27, with a volume of 4020 shares traded. The stock had previously closed at $87.29.

• [By Joseph Griffin]

  Schwab Charles Investment Management Inc. trimmed its position in Columbia Sportswear (NASDAQ:COLM) by 15.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 218,646 shares of the textile maker’s stock after selling 38,455 shares during the period. Schwab Charles Investment Management Inc. owned about 0.31% of Columbia Sportswear worth $20,000,000 as of its most recent SEC filing.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Columbia Sportswear (COLM)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Motley Fool Transcribers]

  Columbia Sportswear Co  (NASDAQ:COLM)Q4 2018 Earnings Conference CallFeb. 07, 2019, 4:15 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Shane Hupp]

  Columbia Sportswear (NASDAQ:COLM) had its target price raised by research analysts at Wedbush from $102.00 to $103.00 in a research report issued on Wednesday. The firm presently has an “outperform” rating on the textile maker’s stock. Wedbush’s price target would indicate a potential upside of 13.99% from the company’s current price.

Top 10 Performing Stocks To Watch Right Now: Cidara Therapeutics, Inc.(CDTX)

Advisors' Opinion:

• [By Trey Thoelcke]

  This small-cap biotech company also has big-time potential. Cidara Therapeutics Inc. (NASDAQ: CDTX) is a clinical-stage biotechnology company is engaged in the discovery, development and commercialization of anti-infectives. It is developing a pipeline of product and development candidates with a focus on serious fungal infections.

• [By Joseph Griffin]

  These are some of the news headlines that may have impacted Accern’s scoring:

  Get Cidara Therapeutics alerts: Statement re Appointment of Matthew Onaitis as Chief Financial Officer (businesswire.com) Mainstay Medical Announces the Appointment of Matthew Onaitis as Chief Financial Officer (businesswire.com) Cidara finance chief bids adieu (seekingalpha.com) Cidara Therapeutics Inc (CDTX) Receives Average Recommendation of “Buy” from Brokerages (americanbankingnews.com)

  Shares of CDTX stock traded down $0.05 on Wednesday, hitting $4.35. 6,508 shares of the stock traded hands, compared to its average volume of 98,568. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.12. The firm has a market cap of $120.40 million, a P/E ratio of -1.37 and a beta of 1.99. Cidara Therapeutics has a 1-year low of $3.65 and a 1-year high of $8.80.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Cidara Therapeutics (CDTX)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Cidara Therapeutics (NASDAQ:CDTX) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.80) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.70) by ($0.10), Bloomberg Earnings reports.

• [By Ethan Ryder]

  Cantor Fitzgerald set a $15.00 target price on Cidara Therapeutics (NASDAQ:CDTX) in a report released on Tuesday morning. The firm currently has a buy rating on the biotechnology company’s stock.

• [By Stephan Byrd]

  These are some of the media headlines that may have impacted Accern Sentiment’s analysis:

  Get Cidara Therapeutics alerts: Cidara Therapeutics (CDTX) Upgraded to Buy at WBB Securities (americanbankingnews.com) Data to be Presented at ASM Microbe 2018 Demonstrate the Efficacy and Safety of Cidara's Rezafungin for the Treatment of Invasive Fungal Infections (finance.yahoo.com) Cidara Therapeutics and Rutgers University awarded $5.5M grant from NIH to develop immunotherapy agents targeting gram-negative bacterial infections (seekingalpha.com) Cidara Therapeutics Announces Offering of Common Stock and Warrants (finance.yahoo.com) Cidara Therapeutics and Rutgers University Awarded $5.5 Million Grant from NIH to Support Development of Novel Immunotherapy Agents Targeting Multi-drug Resistant Gram-negative Bacterial Infections (finance.yahoo.com)

  Shares of CDTX stock traded up $0.30 during trading on Wednesday, hitting $5.20. 311,700 shares of the company were exchanged, compared to its average volume of 203,168. The company has a debt-to-equity ratio of 0.15, a quick ratio of 5.99 and a current ratio of 5.99. The stock has a market cap of $97.33 million, a P/E ratio of -1.64 and a beta of 2.05. Cidara Therapeutics has a twelve month low of $3.70 and a twelve month high of $8.80.

Top 10 Performing Stocks To Watch Right Now: 21Vianet Group, Inc.(VNET)

Advisors' Opinion:

• [By Joseph Griffin]

  BidaskClub upgraded shares of 21Vianet Group (NASDAQ:VNET) from a sell rating to a hold rating in a research report released on Tuesday.

  A number of other equities research analysts have also recently issued reports on VNET. ValuEngine upgraded shares of 21Vianet Group from a sell rating to a hold rating in a report on Wednesday, May 2nd. Zacks Investment Research upgraded shares of 21Vianet Group from a hold rating to a buy rating and set a $8.75 price objective for the company in a report on Thursday, May 24th.

• [By Joseph Griffin]

  21Vianet Group Inc (NASDAQ:VNET) rose 5.8% during mid-day trading on Thursday . The stock traded as high as $8.30 and last traded at $8.27. Approximately 927,613 shares changed hands during mid-day trading, an increase of 101% from the average daily volume of 460,831 shares. The stock had previously closed at $7.82.

• [By Money Morning News Team]

  Seadrill's rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill's gains already on the books, we'll look at a stock that's on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

  Penny Stock Current Share Price Law Week's Gain Seadrill Ltd. (NYSE: SDRL) $0.58 98.74% Vivis Inc. (Nasdaq: VVUS) $0.83 59.97% MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40% Transenterix Inc. (NYSE: TRXC) $3.15 35.72% Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38% Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58% Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22% Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37% Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03% 21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

  These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

• [By Ethan Ryder]

  21Vianet Group (NASDAQ:VNET) will be issuing its quarterly earnings data after the market closes on Monday, March 4th. Analysts expect the company to announce earnings of $0.10 per share for the quarter.

• [By Stephan Byrd]

  21Vianet Group (NASDAQ:VNET) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Tuesday.

• [By Logan Wallace]

  Media stories about 21Vianet Group (NASDAQ:VNET) have been trending somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. 21Vianet Group earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news headlines about the information technology services provider an impact score of 46.0521661520356 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Performing Stocks To Watch Right Now: Balchem Corporation(BCPC)

Advisors' Opinion:

• [By Logan Wallace]

  JPMorgan Chase & Co. boosted its position in shares of Balchem Co. (NASDAQ:BCPC) by 20.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,196 shares of the basic materials company’s stock after buying an additional 12,487 shares during the period. JPMorgan Chase & Co.’s holdings in Balchem were worth $5,985,000 at the end of the most recent quarter.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Balchem (BCPC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Balchem Co. (NASDAQ:BCPC) – Equities research analysts at Seaport Global Securities lifted their Q2 2019 EPS estimates for shares of Balchem in a report issued on Thursday, February 28th. Seaport Global Securities analyst B. Hundley now forecasts that the basic materials company will post earnings per share of $0.81 for the quarter, up from their prior forecast of $0.80. Seaport Global Securities currently has a “Neutral” rating on the stock. Seaport Global Securities also issued estimates for Balchem’s Q3 2019 earnings at $0.78 EPS, Q4 2019 earnings at $0.83 EPS, FY2019 earnings at $3.15 EPS and FY2020 earnings at $3.30 EPS.

• [By Travis Hoium]

  Nearly every business Balchem (NASDAQ:BCPC) is in has seen strong growth in 2018, and that's driving the company's financial results higher. Fracking is seeing the biggest growth, but human and animal health continue to be great businesses for the company. 

Top 10 Performing Stocks To Watch Right Now: Pingtan Marine Enterprise Ltd.(PME)

Advisors' Opinion:

• [By Stephan Byrd]

  Pingtan Marine Enterprise (NASDAQ:PME) CEO Xinrong Zhuo purchased 50,000 shares of Pingtan Marine Enterprise stock in a transaction on Thursday, May 17th. The shares were acquired at an average price of $3.66 per share, with a total value of $183,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

• [By Stephan Byrd]

  Pingtan Marine Enterprise Ltd (NASDAQ:PME) CEO Xinrong Zhuo purchased 50,000 shares of the company’s stock in a transaction on Friday, May 25th. The shares were purchased at an average price of $3.33 per share, for a total transaction of $166,500.00. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website.

Top 10 Performing Stocks To Watch Right Now: Monmouth Real Estate Investment Corporation(MNR)

Advisors' Opinion:

• [By Max Byerly]

  M&T Bank Corp trimmed its position in Monmouth R.E. Inv. Corp. (NYSE:MNR) by 2.1% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 109,456 shares of the real estate investment trust’s stock after selling 2,301 shares during the period. M&T Bank Corp’s holdings in Monmouth R.E. Inv. were worth $1,358,000 at the end of the most recent reporting period.

• [By Ethan Ryder]

  Eagle Asset Management Inc. boosted its holdings in Monmouth R.E. Inv. Corp. (NYSE:MNR) by 0.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 524,288 shares of the real estate investment trust’s stock after purchasing an additional 1,268 shares during the quarter. Eagle Asset Management Inc. owned 0.57% of Monmouth R.E. Inv. worth $6,501,000 at the end of the most recent reporting period.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Monmouth Real Estate Investment (MNR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch Right Now: Matador Resources Company(MTDR)

Advisors' Opinion:

• [By Shane Hupp]

  Several institutional investors and hedge funds have recently made changes to their positions in MTDR. Rehmann Capital Advisory Group raised its position in shares of Matador Resources by 1,042.9% in the 4th quarter. Rehmann Capital Advisory Group now owns 1,863 shares of the energy company’s stock valued at $29,000 after purchasing an additional 1,700 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Matador Resources by 64.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,550 shares of the energy company’s stock valued at $40,000 after purchasing an additional 1,000 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in shares of Matador Resources by 1,453.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 634,633 shares of the energy company’s stock valued at $41,000 after purchasing an additional 593,768 shares in the last quarter. NumerixS Investment Technologies Inc raised its position in shares of Matador Resources by 89.4% in the 4th quarter. NumerixS Investment Technologies Inc now owns 8,002 shares of the energy company’s stock valued at $124,000 after purchasing an additional 3,777 shares in the last quarter. Finally, Dupont Capital Management Corp acquired a new position in shares of Matador Resources in the 4th quarter valued at approximately $152,000. 88.12% of the stock is currently owned by institutional investors.

  TRADEMARK VIOLATION NOTICE: “Matador Resources (MTDR) Shares Up 6%” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/4155370/matador-resources-mtdr-shares-up-6.html.

  About Matador Resources (NYSE:MT

• [By Ethan Ryder]

  Matador Resources Co (NYSE:MTDR) – Stock analysts at Imperial Capital raised their Q3 2018 earnings per share (EPS) estimates for Matador Resources in a report issued on Thursday, October 4th. Imperial Capital analyst I. Haas now anticipates that the energy company will post earnings of $0.43 per share for the quarter, up from their prior forecast of $0.41. Imperial Capital currently has a “Outperform” rating and a $45.00 price objective on the stock. Imperial Capital also issued estimates for Matador Resources’ Q4 2018 earnings at $0.43 EPS, FY2018 earnings at $1.63 EPS, Q1 2019 earnings at $0.41 EPS, Q2 2019 earnings at $0.45 EPS, Q3 2019 earnings at $0.49 EPS, Q4 2019 earnings at $0.60 EPS and FY2019 earnings at $1.96 EPS.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Matador Resources (MTDR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Matador Resources (MTDR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Watch Right Now: Hancock Holding Company(HBHC)

Advisors' Opinion:

• [By Max Byerly]

  Wells Fargo & Company MN boosted its stake in shares of Hancock Holding (NASDAQ:HBHC) by 9.0% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,114,046 shares of the financial services provider’s stock after purchasing an additional 92,265 shares during the period. Wells Fargo & Company MN’s holdings in Hancock were worth $51,970,000 at the end of the most recent quarter.

Top 10 Performing Stocks To Watch Right Now: Constellium N.V.(CSTM)

Advisors' Opinion:

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Constellium (CSTM)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  ValuEngine cut shares of Constellium (NYSE:CSTM) from a strong-buy rating to a buy rating in a research note issued to investors on Tuesday.

  Several other analysts also recently weighed in on the stock. Morgan Stanley set a $15.00 price target on shares of Constellium and gave the stock a buy rating in a research note on Wednesday, February 28th. Societe Generale downgraded shares of Constellium from a buy rating to a hold rating in a research note on Wednesday, February 28th. Seaport Global Securities raised shares of Constellium from a neutral rating to a buy rating and boosted their price target for the stock from $14.00 to $16.00 in a research note on Friday, April 27th. Goldman Sachs Group began coverage on shares of Constellium in a research note on Tuesday, March 20th. They issued a buy rating and a $16.00 price target for the company. Finally, BMO Capital Markets boosted their price target on shares of Constellium from $13.00 to $14.00 and gave the stock a market perform rating in a research note on Friday, April 27th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Constellium currently has an average rating of Buy and a consensus price target of $16.20.

• [By Logan Wallace]

  Motley Fool Wealth Management LLC grew its position in shares of Constellium NV (NYSE:CSTM) by 4.6% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 522,644 shares of the industrial products company’s stock after purchasing an additional 22,954 shares during the period. Motley Fool Wealth Management LLC owned approximately 0.50% of Constellium worth $5,383,000 as of its most recent SEC filing.

• [By Shane Hupp]

  Deutsche Bank set a $15.00 price objective on Constellium (NYSE:CSTM) in a research note published on Tuesday morning. The brokerage currently has a buy rating on the industrial products company’s stock.

ValuEngine Upgrades Lexicon Pharmaceuticals (LXRX) to Hold

Lexicon Pharmaceuticals (NASDAQ:LXRX) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Tuesday.

LXRX has been the subject of a number of other research reports. Zacks Investment Research raised shares of Lexicon Pharmaceuticals from a “hold” rating to a “buy” rating and set a $7.00 price objective for the company in a research report on Wednesday, January 2nd. Citigroup reaffirmed a “buy” rating and set a $14.00 price objective on shares of Lexicon Pharmaceuticals in a research report on Tuesday, January 22nd. They noted that the move was a valuation call. BidaskClub lowered shares of Lexicon Pharmaceuticals from a “sell” rating to a “strong sell” rating in a research report on Wednesday, December 5th. Finally, Wedbush set a $36.00 price objective on shares of Lexicon Pharmaceuticals and gave the company an “outperform” rating in a research report on Tuesday, January 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $20.38.

Get Lexicon Pharmaceuticals alerts:

Shares of LXRX traded up $0.24 during trading hours on Tuesday, reaching $7.17. 807,934 shares of the company traded hands, compared to its average volume of 851,015. The firm has a market capitalization of $738.30 million, a P/E ratio of -5.65 and a beta of 0.63. Lexicon Pharmaceuticals has a 1-year low of $4.26 and a 1-year high of $13.97.

Several institutional investors and hedge funds have recently made changes to their positions in LXRX. Clearbridge Investments LLC raised its position in Lexicon Pharmaceuticals by 974,268.4% in the third quarter. Clearbridge Investments LLC now owns 1,295,910 shares of the biopharmaceutical company’s stock worth $13,827,000 after purchasing an additional 1,295,777 shares in the last quarter. D. E. Shaw & Co. Inc. raised its position in Lexicon Pharmaceuticals by 181.5% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 268,476 shares of the biopharmaceutical company’s stock worth $1,783,000 after purchasing an additional 173,096 shares in the last quarter. Norges Bank acquired a new position in Lexicon Pharmaceuticals in the fourth quarter worth about $1,005,000. First Trust Advisors LP acquired a new position in Lexicon Pharmaceuticals in the third quarter worth about $1,525,000. Finally, Candriam Luxembourg S.C.A. raised its position in Lexicon Pharmaceuticals by 36.8% in the third quarter. Candriam Luxembourg S.C.A. now owns 509,000 shares of the biopharmaceutical company’s stock worth $5,431,000 after purchasing an additional 137,000 shares in the last quarter.

Lexicon Pharmaceuticals Company Profile

Lexicon Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of human diseases. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults.

Read More: Preferred Stock

To view ValuEngine’s full report, visit ValuEngine’s official website.

2019 IPOs Affecting Real Estate In Silicon Valley

&l;p&g;&a;nbsp;

&l;/p&g;&l;div class=&q;mceTemp&q;&g; &l;img class=&q;size-full wp-image-46&q; src=&q;http://blogs-images.forbes.com/nataliakarayaneva/files/2019/03/sv-cover-image.jpg?width=960&q; alt=&q;&q; data-height=&q;563&q; data-width=&q;1000&q;&g; For decades now, Silicon Valley has been considered the center of the tech world when it comes to innovation. &l;p class=&q;graf graf--p&q;&g;Major brands including Uber, Lyft, Slack, Pinterest, and Airbnb are predicted to IPO this year which could result in new wealth, not only for cities where these companies are headquartered but surrounding cities as well.&l;/p&g; &l;p class=&q;graf graf--p&q;&g;The knowledge and tech economy&a;#8202;&a;mdash;&a;#8202;universities, start-up industries, innovation hubs, and parks&a;#8202;&a;mdash;&a;#8202;have always been key drivers of future growth. For decades now, Silicon Valley has been considered the center of the tech world when it comes to innovation. This has resulted in Silicon Valley housing being one of the highest priced real estate markets in the United States, if not globally. And it looks like 2019 may exacerbate that.&l;/p&g; &l;img class=&q;size-full wp-image-45&q; src=&q;http://blogs-images.forbes.com/nataliakarayaneva/files/2019/03/sf-map-700.jpg?width=960&q; alt=&q;&q; data-height=&q;700&q; data-width=&q;700&q;&g; Uber, Lyft, Slack, Pinterest, and Airbnb are predicted to IPO this year which could result in new wealth &l;p class=&q;graf graf--p&q;&g;When tech Unicorn startups, like Uber, finally go public, they will likely be worth over $100 billion, putting at least $10 million in stock for every early employee, advisor, and investor. In addition to the startup ecosystem, the real estate landscape will also be affected. &l;a class=&q;markup--anchor markup--p-anchor&q; href=&q;https://www.bayareamarketreports.com/trend/3-recessions-2-bubbles-and-a-baby&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;Back in 2004, Google&a;rsquo;s IPO played a role in the 11% increase in prices in the San Francisco &l;/a&g;and Bay Area. The economic success of the region, especially it&a;rsquo;s recovery after the great financial crisis, has generally tended to push prices up. Another example is Facebook. It&a;rsquo;s IPO helped its employees make significant down payments on mortgages and early employees invested in more than one single-family homes. While Facebook chose a historically poor area for its HQ, the prices of the &l;a class=&q;markup--anchor markup--p-anchor&q; href=&q;https://www.mercurynews.com/2012/06/07/facebooks-big-jump-was-in-menlo-park-home-prices-2/&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;neighboring Palo Alto and Menlo Park went soaring after the company went public&l;/a&g;.&l;/p&g; &l;p class=&q;graf graf--p&q;&g;The post-IPO availability of cash is in stark contrast with the continuing cooling down of the U.S. real estate market as a whole. Along with IPOs, company expansions in certain areas can also affect the real estate price and rental momentum.&l;a class=&q;markup--anchor markup--p-anchor&q; href=&q;https://streeteasy.com/blog/long-island-city-home-prices-amazon/&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g; Interest and property prices in New York saw a significant increase&l;/a&g; in Long Island City when in November the news broke that Amazon would build a vast campus for its headquarter. But what we may expect after the company recently announced their decision to drop the expansion plans in New York? Following the euphoria and the tremendous property searches, now sellers are worried whether the market will react negatively, and agents, on the other hand, feel insecure for the deals already in progress.&l;/p&g; &l;p class=&q;graf graf--p&q;&g;While 2018 was a rather crazy and fast &a;ldquo;seller&a;rsquo;s market,&a;rdquo; it is expected that things will be a little different in 2019 as buyers and sellers adjust to the new realities. Meanwhile, if the upcoming IPOs happen before Q3, new cash buyers will target not only prime Silicon Valley areas, such as Atherton but also vacation places like Tahoe and even affordable European properties. One thing is for sure, 2019 will be one of the most exciting and dynamic years for Silicon Valley real estate.&l;/p&g; &l;/div&g;&l;p class=&q;tweet_line&q;&g;Uber, Lyft, Slack, Pinterest, and Airbnb are predicted to IPO this year which could result in new wealth&l;/p&g;&l;p class=&q;tweet_line&q;&g;The post-IPO availability of cash is in stark contrast with the continuing cooling down of the U.S. real estate market&l;span&g; &l;/span&g;

Best High Tech Stocks To Buy For 2019

tags:NGD,VPV,KMM,HAWK,FRME,

All working Americans need retirement savings, regardless of gender. But the need is particularly strong for women, since they have a tendency to live longer than their male counterparts. As such, they're also more likely to require paid care at some point -- as a spouse may not be around to provide care.

It's therefore unsettling to learn that women are only saving about half as much as men for the future. In a recent Student Loan Hero study, women had an average of $45,614 socked away for retirement, whereas men had $90,189. That sort of gap could put women at a severe disadvantage later in life.

IMAGE SOURCE: GETTY IMAGES.

Why are women falling behind savings-wise?

When asked why they're struggling to save for retirement, women cited living paycheck to paycheck and having to pay back student loans as their greatest deterrents. Then again, so did men. So why is it that the average female saver only has about half as much as her male counterpart?

Best High Tech Stocks To Buy For 2019: NEW GOLD INC.(NGD)

Advisors' Opinion:

• [By Maxx Chatsko]

  Shares of New Gold (NYSEMKT:NGD) fell by over 14% today after the company announced the surprise sale of its Mesquite gold mine. The business will receive $158 million in cash for the productive asset, which management says will "immediately crystallize several years' worth of future free cash flow as part of our strategy to prudently manage our balance sheet, providing the company with the financial flexibility to focus on our core assets".

• [By WWW.GURUFOCUS.COM]

  For the details of Exor Investments (UK) LLP's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Exor+Investments+%28UK%29+LLP

  These are the top 5 holdings of Exor Investments (UK) LLPSibanye-Stillwater (SBGL) - 45,970,311 shares, 32.51% of the total portfolio. Shares added by 8.09%VEON Ltd (VEON) - 37,657,792 shares, 31.02% of the total portfolio. Shares added by 3.83%Cameco Corp (CCJ) - 5,967,410 shares, 19.32% of the total portfolio. Harmony Gold Mining Co Ltd (HMY) - 13,275,728 shares, 6.26% of the total portfolio. Shares added by 6.84%Novagold Resources Inc (NG) - 5,889,905 shares, 6.21% of the total portfolio. Shares
• [By Paul Ausick]

  New Gold Inc. (NYSE: NGD) dropped about 4.7% Friday to post a new 52-week low of $2.05. Shares closed at $2.15 on Thursday and the stock’s 52-week high is $4.25. Volume was about 50% higher than the daily average of 4.2 million. The junior gold miner had no specific news.

• [By Stephan Byrd]

  JPMorgan Chase & Co. downgraded shares of New Gold (NYSEAMERICAN:NGD) from a neutral rating to an underweight rating in a research report released on Wednesday, The Fly reports.

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Check-Cap Ltd. (NASDAQ: CHEK) fell 23.3 percent to $9.87 in pre-market trading after declining 13.45 percent on Wednesday. SunCoke Energy Partners, L.P. (NYSE: SXCP) fell 12.8 percent to $16.00 in pre-market trading after reporting Q1 results. Briggs & Stratton Corporation (NYSE: BGG) fell 11 percent to $17.55 in pre-market trading after the company posted mixed Q3 results and lowered its FY18 guidance. New Gold Inc. (NYSE: NGD) fell 8.4 percent to $2.30 in pre-market trading following downbeat Q1 results. Quality Care Properties, Inc. (NYSE: QCP) fell 8.2 percent to $20.85 in pre-market trading. Welltower announced plans to acquire QCP for $20.75 per share in cash. China Customer Relations Centers Inc. (NASDAQ: CCRC) shares fell 7.5 percent to $17.25 in pre-market trading after climbing 18.73 percent on Wednesday. Nokia Corporation (NYSE: NOK) shares fell 5.7 percent to $5.58 in pre-market trading after reporting Q1 results. eBay Inc. (NASDAQ: EBAY) fell 5.6 percent to $38.66 in pre-market trading following Q1 results. Southw

Best High Tech Stocks To Buy For 2019: Invesco Pennsylvania Value Municipal Income Trust(VPV)

Advisors' Opinion:

• [By Stephan Byrd]

  News stories about Invesco Pennsylvania Value Mncpl Incm Tr (NYSE:VPV) have been trending very positive recently, Accern reports. The research group scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Invesco Pennsylvania Value Mncpl Incm Tr earned a news impact score of 0.65 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 48.6094961265878 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Best High Tech Stocks To Buy For 2019: Scudder Multi-Market Income Trust(KMM)

Advisors' Opinion:

• [By Logan Wallace]

  Shaker Financial Services LLC trimmed its position in shares of Scudder Multi-Market Income Trust (NYSE:KMM) by 9.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 176,961 shares of the investment management company’s stock after selling 18,837 shares during the quarter. Shaker Financial Services LLC’s holdings in Scudder Multi-Market Income Trust were worth $1,554,000 at the end of the most recent reporting period.

Best High Tech Stocks To Buy For 2019: Blackhawk Network Holdings, Inc.(HAWK)

Advisors' Opinion:

• [By Max Byerly]

  Shares of Blackhawk Network Holdings (NASDAQ:HAWK) have been given a consensus rating of “Hold” by the eighteen ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $44.75.

Best High Tech Stocks To Buy For 2019: First Merchants Corporation(FRME)

Advisors' Opinion:

• [By Shane Hupp]

  CBTX (NASDAQ: FRME) and First Merchants (NASDAQ:FRME) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability.

• [By Logan Wallace]

  First Merchants Co. (NASDAQ:FRME) insider Stephan Fluhler sold 1,047 shares of the stock in a transaction that occurred on Wednesday, June 20th. The shares were sold at an average price of $48.00, for a total value of $50,256.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

• [By Joseph Griffin]

  Meeder Asset Management Inc. decreased its holdings in shares of First Merchants Co. (NASDAQ:FRME) by 26.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,664 shares of the bank’s stock after selling 1,677 shares during the quarter. Meeder Asset Management Inc.’s holdings in First Merchants were worth $195,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  First Merchants Co. (NASDAQ:FRME) President Michael C. Rechin sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, August 20th. The stock was sold at an average price of $48.63, for a total value of $729,450.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Head-To-Head Comparison: Eversource Energy (ES) vs. Empresa Distribuidora y Cmrz Nrt (EDN)

Eversource Energy (NYSE:ES) and Empresa Distribuidora y Cmrz Nrt (NYSE:EDN) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, profitability and earnings.

Dividends

Get Eversource Energy alerts:

Eversource Energy pays an annual dividend of $2.02 per share and has a dividend yield of 2.9%. Empresa Distribuidora y Cmrz Nrt does not pay a dividend. Eversource Energy pays out 61.6% of its earnings in the form of a dividend. Eversource Energy has raised its dividend for 3 consecutive years.

Profitability

This table compares Eversource Energy and Empresa Distribuidora y Cmrz Nrt’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Eversource Energy	12.23%	9.22%	2.79%
Empresa Distribuidora y Cmrz Nrt	5.09%	112.26%	6.41%

Analyst Recommendations

This is a summary of recent recommendations and price targets for Eversource Energy and Empresa Distribuidora y Cmrz Nrt, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eversource Energy	2	4	8	0	2.43
Empresa Distribuidora y Cmrz Nrt	2	0	0	0	1.00

Eversource Energy currently has a consensus target price of $67.91, suggesting a potential downside of 2.13%. Empresa Distribuidora y Cmrz Nrt has a consensus target price of $26.50, suggesting a potential upside of 8.83%. Given Empresa Distribuidora y Cmrz Nrt’s higher possible upside, analysts plainly believe Empresa Distribuidora y Cmrz Nrt is more favorable than Eversource Energy.

Risk & Volatility

Eversource Energy has a beta of 0.32, suggesting that its share price is 68% less volatile than the S&P 500. Comparatively, Empresa Distribuidora y Cmrz Nrt has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Insider & Institutional Ownership

73.4% of Eversource Energy shares are owned by institutional investors. Comparatively, 7.3% of Empresa Distribuidora y Cmrz Nrt shares are owned by institutional investors. 0.5% of Eversource Energy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Eversource Energy and Empresa Distribuidora y Cmrz Nrt’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eversource Energy	$8.45 billion	2.60	$987.99 million	$3.28	21.16
Empresa Distribuidora y Cmrz Nrt	$1.47 billion	0.75	$41.20 million	($1.00)	-24.35

Eversource Energy has higher revenue and earnings than Empresa Distribuidora y Cmrz Nrt. Empresa Distribuidora y Cmrz Nrt is trading at a lower price-to-earnings ratio than Eversource Energy, indicating that it is currently the more affordable of the two stocks.

Summary

Eversource Energy beats Empresa Distribuidora y Cmrz Nrt on 12 of the 17 factors compared between the two stocks.

Eversource Energy Company Profile

Eversource Energy, a public utility holding company, engages in the energy delivery business. The company operates in three segments: Electric Distribution, Electric Transmission, and Natural Gas Distribution. It is involved in the transmission and distribution of electricity; and distribution of natural gas. The company operates water regulated utilities. It also provides water services to approximately 226,000 customers. It serves residential, commercial, industrial, municipal, fire protection, and other customers in Connecticut, Massachusetts, and New Hampshire, the United States. The company was formerly known as Northeast Utilities and changed its name to Eversource Energy in April 2015. Eversource Energy was founded in 1927 and is based in Springfield, Massachusetts.

Empresa Distribuidora y Cmrz Nrt Company Profile

Empresa Distribuidora y Comercializadora Norte Sociedad Anónima, a public service company, engages in the distribution and sale of electricity in Argentina. It serves approximately 8.5 million people in the northwestern part of the greater Buenos Aires metropolitan area and the northern part of the City of Buenos Aires through the concession of 4,637 square kilometers. The company was formerly known as Empresa Distribuidora Norte Sociedad Anónima and changed its name to Empresa Distribuidora y Comercializadora Norte Sociedad Anónima in June 1996. The company was founded in 1992 and is based in Buenos Aires, Argentina. Empresa Distribuidora y Comercializadora Norte Sociedad Anónima is a subsidiary of Electricidad Argentina S.A.

Why CoStar Group Stock Popped 17% in February

What happened

Shares of CoStar Group (NASDAQ:CSGP) climbed 17.1% last month, according to data provided by S&P Global Market Intelligence, after the real estate information provider delivered a strong fourth-quarter report and issued upbeat guidance for the year ahead.

So what

CoStar Group's fourth-quarter revenue jumped 24% to $316 million. Profit growth was even more impressive: Net income surged 89% to $84 million, while adjusted net income soared 126% to $102 million. 

CoStar is enjoying solid growth across all of its major business segments. Its CoStar Suite information product saw revenue rise 16% to $142 million. Meanwhile, sales in its multifamily marketplace business leapt 44% to $109 million, driven by the strong growth of Apartments.com. 

Additionally, CEO Andrew Florance said during a conference call with analysts that the company believes it can more than triple revenue at its LoopNet commercial real estate marketplace in the coming years.  

Image source: Getty Images.

Now what

CoStar Group expects companywide revenue to rise another 15% to approximately $1.38 billion in 2019. Management is also guiding for adjusted earnings to increase by as much as 21% to $10 per share. 

Looking even further ahead, Florance said that CoStar Group is targeting a $3 billion revenue run rate by the end of 2023. That would represent a near-tripling of the $1.2 billion in revenue the company generated in 2018.

All told, CoStar Group's shares are now up almost 35% so far in 2019, but if Florance and his team can deliver on their aggressive growth targets, more gains could still lie ahead for investors.

Fiera Capital Corp Has $38.54 Million Position in Tripadvisor Inc (TRIP)

Fiera Capital Corp lowered its position in Tripadvisor Inc (NASDAQ:TRIP) by 2.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 714,552 shares of the travel company’s stock after selling 19,634 shares during the period. Fiera Capital Corp’s holdings in Tripadvisor were worth $38,543,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in TRIP. Strs Ohio grew its stake in shares of Tripadvisor by 34.1% in the 3rd quarter. Strs Ohio now owns 6,326 shares of the travel company’s stock valued at $323,000 after buying an additional 1,609 shares during the period. Russell Investments Group Ltd. lifted its position in Tripadvisor by 11.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 191,691 shares of the travel company’s stock valued at $9,795,000 after acquiring an additional 18,974 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its position in Tripadvisor by 175.4% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 99,706 shares of the travel company’s stock valued at $5,092,000 after acquiring an additional 63,507 shares in the last quarter. Chicago Equity Partners LLC bought a new position in Tripadvisor in the 3rd quarter valued at about $452,000. Finally, Daiwa Securities Group Inc. lifted its position in Tripadvisor by 43.5% in the 3rd quarter. Daiwa Securities Group Inc. now owns 58,541 shares of the travel company’s stock valued at $2,989,000 after acquiring an additional 17,751 shares in the last quarter. 87.39% of the stock is owned by hedge funds and other institutional investors.

Get Tripadvisor alerts:

Tripadvisor stock opened at $52.32 on Wednesday. Tripadvisor Inc has a 52 week low of $36.75 and a 52 week high of $69.00. The company has a market cap of $7.56 billion, a price-to-earnings ratio of 49.83, a PEG ratio of 3.39 and a beta of 1.49.

Tripadvisor (NASDAQ:TRIP) last posted its earnings results on Tuesday, February 12th. The travel company reported $0.27 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.15 by $0.12. Tripadvisor had a net margin of 7.00% and a return on equity of 9.27%. The firm had revenue of $346.00 million for the quarter, compared to analysts’ expectations of $342.90 million. During the same quarter last year, the firm earned $0.06 EPS. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. On average, sell-side analysts forecast that Tripadvisor Inc will post 1.26 earnings per share for the current year.

In other Tripadvisor news, insider Dermot Halpin sold 17,655 shares of Tripadvisor stock in a transaction that occurred on Friday, February 15th. The shares were sold at an average price of $56.69, for a total transaction of $1,000,861.95. Following the transaction, the insider now owns 21,791 shares of the company’s stock, valued at approximately $1,235,331.79. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Ernst 02494 Teunissen sold 15,418 shares of Tripadvisor stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $53.08, for a total transaction of $818,387.44. Following the transaction, the chief financial officer now directly owns 12,668 shares in the company, valued at approximately $672,417.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 47,729 shares of company stock worth $2,627,528. Insiders own 3.10% of the company’s stock.

Several equities analysts recently weighed in on TRIP shares. Zacks Investment Research raised shares of Tripadvisor from a “hold” rating to a “strong-buy” rating and set a $72.00 price target on the stock in a research report on Saturday, November 17th. DA Davidson raised their price target on shares of Tripadvisor to $62.00 and gave the company a “neutral” rating in a research report on Friday, November 9th. They noted that the move was a valuation call. UBS Group cut shares of Tripadvisor from a “neutral” rating to a “sell” rating and raised their price target for the company from $47.00 to $50.00 in a research report on Friday, November 9th. Piper Jaffray Companies raised their price target on shares of Tripadvisor to $58.00 and gave the company a “neutral” rating in a research report on Wednesday, February 13th. Finally, Bank of America raised their price target on shares of Tripadvisor from $38.00 to $43.00 and gave the company an “underperform” rating in a research report on Thursday, November 8th. Four research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $56.63.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/4200832/fiera-capital-corp-has-38-54-million-position-in-tripadvisor-inc-trip.html.

Tripadvisor Company Profile

TripAdvisor, Inc operates as an online travel company. The company operates in two segments, Hotel and Non-Hotel. Its travel platform aggregates reviews and opinions of members about destinations, accommodations, activities and attractions, and restaurants, which enables users to research and plan their travel experiences, as well as book hotels, flights, cruises, vacation rentals, tours, activities and attractions, and restaurant reservations on its site or mobile app, or on the site or app of travel partner sites.

Further Reading: What Factors Can Affect Return on Equity?

Want to see what other hedge funds are holding TRIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tripadvisor Inc (NASDAQ:TRIP).

Here's 1 Valuable Tax Credit You Don't Want to Miss Out On

Taxes are a burden for working Americans across a wide range of incomes. But lower earners more so than anyone tend to struggle to keep up.

Thankfully, the IRS offers a bit of relief in the form of the Earned Income Tax Credit, or EITC. For the 2018 tax year, the EITC could be worth up to $6,431, so it pays to see whether you qualify for it.

How tax credits work

Unlike a tax deduction, which simply exempts a portion of your income from taxes, a tax credit is a dollar-for-dollar reduction of your tax liability. This means that if you qualify for a $2,000 tax credit, $2,000 automatically gets subtracted from your tax bill.

Image source: Getty Images.

Now many tax credits are nonrefundable, which means the most they can do is knock your tax liability down to $0. For example, if you owe the IRS $500 in taxes but qualify for a $1,000 tax credit, you won't get that $500 difference if the credit in question in nonrefundable. The EITC, however, is one of the few tax credits that is refundable, which means that if it lowers your tax burden below $0, the IRS will send you the difference.

Qualifying for the EITC

The EITC is designed to help lower earners, and to qualify for the credit, you will need earned income from a job or business that you own. Also, your tax filing status must be one of the following:

Single Married filing jointly Head of household Qualifying widow

Additionally, you can't have investment income in excess of $3,500 if you want to claim the EITC.

If you meet the above criteria, you can claim the EITC if you have the following number of qualifying children in your household and your earnings don't exceed the following limits:

Tax Filing Status

No Qualifying Children

1 Qualifying Child

2 Qualifying Children

3 or More Qualifying Children

Single, head of household, or widowed	$15,270	$40,320	$45,802	$49,194
Married filing jointly	$20,950	$46,010	$51,492	$54,884

Data source: IRS.

Keep in mind that if you have children, there are other tax credits you might be eligible for, like the Child Tax Credit or the Child and Dependent Care Credit (if you pay for child care in order to work). You're allowed to claim multiple credits on your taxes, so it pays to explore your options.

As far as the EITC's value goes, it'll depend on the number of children in your household, as follows:

Number of Qualifying Children

Maximum Value of EITC

0	$519
1	$3,461
2	$5,716
3	$6,431

Data source: IRS.

Now remember how we talked about the fact that the EITC is a refundable tax credit? If your tax liability is $0 and you qualify for the EITC's maximum value, the IRS will send you $6,431. To get that money, however, you'll need to file a tax return and actually claim the credit -- something an astounding 20% of eligible filers fail to do every year.

One final thing: The above earning limits and credit values apply to the 2018 tax year -- meaning, the tax return you'll be filing this year. In 2019, you can earn slightly more and still claim the credit if you otherwise qualify. The maximum value of the EITC has also gone up to $6,557 for the 2019 tax year, so if you claim it on your 2018 taxes, be sure to keep it on your radar for the following year as well.